Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Total Assets 2012–2025
Crescent Biopharma, Inc. annual total assets history from 2013 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Crescent Biopharma, Inc. total assets as of December 31, 2025: 240.3M, a 430.26% increase year-over-year.
- Crescent Biopharma, Inc. total assets for 2025 were 240.3M, a 430.26% increase from 2023.
- Crescent Biopharma, Inc. total assets for 2023 were 45.3M, a 12.53% decrease from 2022.
- Crescent Biopharma, Inc. total assets for 2022 were 51.8M, a 45.08% decrease from 2021.
- Crescent Biopharma, Inc. total assets for 2021 were 94.3M.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crescent Biopharma, Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $240 |
| 2023 | $45 |
| 2022 | $52 |
| 2021 | $94 |
| 2020 | $143 |
| 2016 | $42 |
| 2015 | $48 |
| 2014 | $57 |
| 2013 | $5 |
Crescent Biopharma, Inc. Total Assets — FAQ
Crescent Biopharma, Inc. (CBIO) total assets over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CBIO's total assets history?
The chart and table above show Crescent Biopharma, Inc.'s total assets by year and by quarter, including the growth rate.